Investigation of the Occurrence of Serotonin Toxicity in Parkinson's Disease (PD) Patients Treated Concomitantly With Rasagiline and Antidepressants, Using Retrospective Chart Review.
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Rasagiline (Primary) ; Antidepressants; Antiparkinsonians
- Indications Parkinson's disease
- Focus Adverse reactions
- Acronyms STACCATO
- Sponsors Teva Pharmaceutical Industries
- 08 Jun 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 08 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2009 New trial record